PMID- 27999175 OWN - NLM STAT- MEDLINE DCOM- 20171120 LR - 20210102 IS - 1937-9145 (Electronic) IS - 1945-0877 (Linking) VI - 9 IP - 459 DP - 2016 Dec 20 TI - Trans-inhibition of activation and proliferation signals by Fc receptors in mast cells and basophils. PG - ra126 LID - 10.1126/scisignal.aag1401 [doi] AB - Allergic and autoimmune inflammation are associated with the activation of mast cells and basophils by antibodies against allergens or auto-antigens, respectively. Both cell types express several receptors for the Fc portion of antibodies, the engagement of which by antigen-antibody complexes controls their responses. When aggregated on the plasma membrane, high-affinity immunoglobulin E (IgE) receptors (FcepsilonRI) and low-affinity IgG receptors (FcgammaRIIIA in mice, FcgammaRIIA in humans) induce these cells to release and secrete proinflammatory mediators, chemokines, and cytokines that account for clinical symptoms. When coaggregated with activating receptors on the same cells, other low-affinity IgG receptors (FcgammaRIIB in both species) inhibit mast cell and basophil activation. We found that FcgammaRIIB inhibited not only signals triggered by activating receptors with which they were coengaged (cis-inhibition), but also signals triggered by receptors engaged independently (trans-inhibition). Trans-inhibition acted upon the FcepsilonRI-dependent activation of mouse mast cells, mouse basophils, and human basophils, and upon growth factor receptor (Kit)-dependent normal mouse mast cell proliferation, as well as the constitutive in vitro proliferation and the in vivo growth of oncogene (v-Abl)-transformed mastocytoma cells. Trans-inhibition was induced by receptors, whether inhibitory (FcgammaRIIB) or activating (FcepsilonRI), which recruited the lipid phosphatase SHIP1. By hydrolyzing PI(3,4,5)P(3), SHIP1 induced a global unresponsiveness that affected biological responses triggered by receptors that use phosphoinositide 3-kinase to signal. These data suggest that trans-inhibition controls numerous physiological and pathological processes, and that it may be used as a therapeutic tool in inflammation, especially but not exclusively, in allergy and autoimmunity. CI - Copyright (c) 2016, American Association for the Advancement of Science. FAU - Malbec, Odile AU - Malbec O AD - Institut Pasteur, Departement d'Immunologie, Unite d'Allergologie Moleculaire et Cellulaire, Paris, France. AD - Inserm, Unite 760, Paris, France. FAU - Cassard, Lydie AU - Cassard L AD - Institut Pasteur, Departement d'Immunologie, Unite d'Allergologie Moleculaire et Cellulaire, Paris, France. AD - Inserm, Unite 760, Paris, France. FAU - Albanesi, Marcello AU - Albanesi M AD - Institut Pasteur, Departement d'Immunologie, Unite d'Allergologie Moleculaire et Cellulaire, Paris, France. AD - Inserm, Unite 760, Paris, France. FAU - Jonsson, Friederike AU - Jonsson F AD - Institut Pasteur, Departement d'Immunologie, Unite d'Allergologie Moleculaire et Cellulaire, Paris, France. AD - Inserm, Unite 760, Paris, France. FAU - Mancardi, David AU - Mancardi D AD - Institut Pasteur, Departement d'Immunologie, Unite d'Allergologie Moleculaire et Cellulaire, Paris, France. AD - Inserm, Unite 760, Paris, France. FAU - Chicanne, Gaetan AU - Chicanne G AD - Inserm, Unite 1048, Toulouse, France. AD - Universite Toulouse 3, Toulouse, France. AD - Institut des Maladies Metaboliques et Cardiovasculaires, Toulouse, France. FAU - Payrastre, Bernard AU - Payrastre B AD - Inserm, Unite 1048, Toulouse, France. AD - Universite Toulouse 3, Toulouse, France. AD - Institut des Maladies Metaboliques et Cardiovasculaires, Toulouse, France. FAU - Dubreuil, Patrice AU - Dubreuil P AD - Inserm, Unite 1068, Centre de Recherche en Cancerologie de Marseille, Marseille, France. AD - Institut Paoli-Calmettes, Marseille, France. AD - Aix Marseille Universite, Marseille, France. AD - CNRS, UMR 7258, Marseille, France. FAU - Vivier, Eric AU - Vivier E AD - Centre d'Immunologie de Marseille-Luminy, Aix Marseille Universite, Inserm, CNRS, Marseille, France. AD - Hopital de la Conception, Marseille, France. FAU - Daeron, Marc AU - Daeron M AD - Institut Pasteur, Departement d'Immunologie, Unite d'Allergologie Moleculaire et Cellulaire, Paris, France. marc.daeron@pasteur.fr. AD - Inserm, Unite 760, Paris, France. AD - Centre d'Immunologie de Marseille-Luminy, Aix Marseille Universite, Inserm, CNRS, Marseille, France. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20161220 PL - United States TA - Sci Signal JT - Science signaling JID - 101465400 RN - 0 (FCGR2A protein, human) RN - 0 (FCGR2B protein, human) RN - 0 (FcgammaRIIIA protein, mouse) RN - 0 (Fcgr2b protein, mouse) RN - 0 (Phosphatidylinositol Phosphates) RN - 0 (Receptors, IgE) RN - 0 (Receptors, IgG) RN - 0 (phosphatidylinositol 3,4,5-triphosphate) RN - EC 2.7.1.- (Phosphatidylinositol 3-Kinases) RN - EC 3.1.3.86 (INPP5D protein, human) RN - EC 3.1.3.86 (Inpp5d protein, mouse) RN - EC 3.1.3.86 (Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases) SB - IM MH - Animals MH - Basophils/*immunology MH - *Cell Proliferation MH - Humans MH - Mast Cells MH - Mice MH - Phosphatidylinositol 3-Kinases/genetics/immunology MH - Phosphatidylinositol Phosphates/genetics/immunology MH - Phosphatidylinositol-3,4,5-Trisphosphate 5-Phosphatases/genetics/immunology MH - Receptors, IgE/*immunology MH - Receptors, IgG/genetics/*immunology MH - Signal Transduction/*immunology EDAT- 2016/12/22 06:00 MHDA- 2017/11/29 06:00 CRDT- 2016/12/22 06:00 PHST- 2016/12/22 06:00 [entrez] PHST- 2016/12/22 06:00 [pubmed] PHST- 2017/11/29 06:00 [medline] AID - 9/459/ra126 [pii] AID - 10.1126/scisignal.aag1401 [doi] PST - epublish SO - Sci Signal. 2016 Dec 20;9(459):ra126. doi: 10.1126/scisignal.aag1401.